Rachel Pearce

2.3k total citations
46 papers, 1.5k citations indexed

About

Rachel Pearce is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Rachel Pearce has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 19 papers in Pathology and Forensic Medicine and 15 papers in Oncology. Recurrent topics in Rachel Pearce's work include Hematopoietic Stem Cell Transplantation (17 papers), Lymphoma Diagnosis and Treatment (17 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Rachel Pearce is often cited by papers focused on Hematopoietic Stem Cell Transplantation (17 papers), Lymphoma Diagnosis and Treatment (17 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Rachel Pearce collaborates with scholars based in United Kingdom, Italy and United States. Rachel Pearce's co-authors include G. Taghipour, Rajesh Chopra, Anthony H. Goldstone, Thierry Philip, AH Goldstone, AK McMillan, DC Linch, Richard Davies, David Crabbe and James Raftery and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Rachel Pearce

42 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel Pearce United Kingdom 20 753 584 473 435 362 46 1.5k
Shirley D’Sa United Kingdom 25 569 0.8× 628 1.1× 1.4k 3.0× 363 0.8× 758 2.1× 122 2.4k
Xavier Rialland France 23 317 0.4× 235 0.4× 198 0.4× 391 0.9× 510 1.4× 45 1.6k
S B Murphy United States 21 673 0.9× 458 0.8× 687 1.5× 382 0.9× 263 0.7× 32 1.9k
Heinz Haverkamp Germany 19 921 1.2× 519 0.9× 121 0.3× 420 1.0× 186 0.5× 53 1.3k
F Deméocq France 22 234 0.3× 312 0.5× 564 1.2× 336 0.8× 231 0.6× 78 1.5k
John Amess United Kingdom 12 619 0.8× 445 0.8× 372 0.8× 124 0.3× 358 1.0× 16 1.3k
H. Riehm Germany 22 263 0.3× 413 0.7× 1.0k 2.2× 293 0.7× 256 0.7× 69 2.1k
Jillian R. Mann United Kingdom 27 263 0.3× 390 0.7× 181 0.4× 518 1.2× 472 1.3× 82 2.2k
Claudine Schmitt France 25 611 0.8× 479 0.8× 411 0.9× 272 0.6× 135 0.4× 60 1.9k
Astrid Franke Germany 13 641 0.9× 403 0.7× 141 0.3× 143 0.3× 392 1.1× 28 1.0k

Countries citing papers authored by Rachel Pearce

Since Specialization
Citations

This map shows the geographic impact of Rachel Pearce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Pearce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Pearce more than expected).

Fields of papers citing papers by Rachel Pearce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Pearce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Pearce. The network helps show where Rachel Pearce may publish in the future.

Co-authorship network of co-authors of Rachel Pearce

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Pearce. A scholar is included among the top collaborators of Rachel Pearce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Pearce. Rachel Pearce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muraro, Paolo A., Eleonora De Matteis, Gavin Brittain, et al.. (2025). Real-world effectiveness of autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK. Journal of Neurology Neurosurgery & Psychiatry. 97(2). jnnp–2025.
4.
Pearce, Rachel, Zohreh Nademi, Giovanna Lucchini, et al.. (2024). Pediatric adapted risk index to predict 2-year transplant-related mortality post-HSCT in children. Blood Advances. 8(22). 5838–5852. 1 indexed citations
5.
O’Hare, Peter, Giovanna Lucchini, M Cummins, et al.. (2017). Allogeneic stem cell transplantation for refractory acute myeloid leukemia in pediatric patients: the UK experience. Bone Marrow Transplantation. 52(6). 825–831. 18 indexed citations
6.
Nikolousis, Emmanouil, Sandeep Nagra, Rachel Pearce, et al.. (2014). Impact of pre-transplant co-morbidities on outcome after alemtuzumab-based reduced intensity conditioning allo-SCT in elderly patients: A British Society of Blood and Marrow Transplantation study. Bone Marrow Transplantation. 50(1). 82–86. 8 indexed citations
7.
Pearce, Rachel & Ramnath Subramaniam. (2011). Minimally invasive partial or total nephrectomy in children: a comparison between transperitoneal and retroperitoneal approaches. Pediatric Surgery International. 27(11). 1233–1237. 4 indexed citations
8.
Pearce, Rachel & Ramnath Subramaniam. (2011). Partial nephroureterectomy in a duplex system in children: the need for additional bladder procedures. Pediatric Surgery International. 27(12). 1323–1326. 7 indexed citations
10.
Cook, Gordon, G Jackson, Gareth J. Morgan, et al.. (2010). The outcome of high-dose chemotherapy and auto-SCT in patients with multiple myeloma: a UK/Ireland and European benchmarking comparative analysis. Bone Marrow Transplantation. 46(9). 1210–1218. 7 indexed citations
11.
Cook, Gordon, Graeme Smith, Keiren Kirkland, et al.. (2010). Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for Relapsed and Refractory Mantle Cell Lymphoma (MCL): A Study of the British Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation. 16(10). 1419–1427. 69 indexed citations
12.
Stewart, Wendy A., Rachel Pearce, Keiren Kirkland, et al.. (2010). The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation study. Bone Marrow Transplantation. 45(11). 1587–1593. 47 indexed citations
13.
14.
Malladi, Ram, Andy Peniket, Tim Littlewood, et al.. (2008). Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AML. Bone Marrow Transplantation. 43(9). 709–715. 22 indexed citations
15.
Roderick, Paul, Richard Davies, James Raftery, et al.. (2003). The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model. Health Technology Assessment. 7(6). 1–86. 109 indexed citations
16.
Pearce, Rachel, et al.. (2001). L -Dopa induces dyskinesia in normal monkeys: behavioural and pharmacokinetic observations. Psychopharmacology. 156(4). 402–409. 75 indexed citations
17.
Dalrymple‐Hay, Malcolm, Rachel Pearce, Sam Dawkins, et al.. (2000). A single-center experience with 1,378 CarboMedics mechanical valve implants. The Annals of Thoracic Surgery. 69(2). 457–463. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026